Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3576973rdf:typepubmed:Citationlld:pubmed
pubmed-article:3576973lifeskim:mentionsumls-concept:C0027984lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:3576973lifeskim:mentionsumls-concept:C1520022lld:lifeskim
pubmed-article:3576973pubmed:issue1lld:pubmed
pubmed-article:3576973pubmed:dateCreated1987-5-26lld:pubmed
pubmed-article:3576973pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:abstractTextThe nucleotide sequence of the mRNA encoding the fusion (F0) protein of a virulent strain of Newcastle disease virus was determined. A single open reading frame in the sequence encodes a protein of 553 amino acids with a calculated molecular weight of 59058. The amino acid sequence predicted several structural features involving the fusion-inducing hydrophobic stretch (residues 117-142) and the cleavage-activation site (residues 112-116) to generate the disulfide-linked F1 and F2 subunits. The cleavage-activation site as well as a part of the fusion-inducing sequence were compared among a series of virulent and avirulent strains by the chain-termination method using a synthetic oligonucleotide primer. It was found that without exception, the cleavage-activation site of virulent strains consisted of two dibasic residues with an intervening glutamine, Arg-Arg-Gln-Arg-Arg, whereas the corresponding region of avirulent strains was made of a sequence with single basic residues scattered among uncharged residues, Gly-LysArg-Gln-GlySer-Arg. On the basis of these observations and the previous results showing a strict correlation between the pathogenicity and the cleavability of the fusion protein of NDV (Y. Nagai, H-D. Klenk, and R. Rott, Virology, 72, 494-508, 1976), we propose the importance of the dibasic residues for efficient proteolytic activation of the fusion protein and for the pantropic property of NDV. Some strains were found to have Leu-Ile-Gly as the N-terminus of F1, whereas others contained Phe-Ile-Gly, indicating that Phe-X-Gly is not always conserved at F1 N-terminus of paramyxovirus.lld:pubmed
pubmed-article:3576973pubmed:languageenglld:pubmed
pubmed-article:3576973pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:citationSubsetIMlld:pubmed
pubmed-article:3576973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3576973pubmed:statusMEDLINElld:pubmed
pubmed-article:3576973pubmed:monthMaylld:pubmed
pubmed-article:3576973pubmed:issn0042-6822lld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:ImaiKKlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:NagaiYYlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:HamaguchiMMlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:ToyodaTTlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:SakaguchiTTlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:GotohBBlld:pubmed
pubmed-article:3576973pubmed:authorpubmed-author:InocencioN...lld:pubmed
pubmed-article:3576973pubmed:issnTypePrintlld:pubmed
pubmed-article:3576973pubmed:volume158lld:pubmed
pubmed-article:3576973pubmed:ownerNLMlld:pubmed
pubmed-article:3576973pubmed:authorsCompleteYlld:pubmed
pubmed-article:3576973pubmed:pagination242-7lld:pubmed
pubmed-article:3576973pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:meshHeadingpubmed-meshheading:3576973-...lld:pubmed
pubmed-article:3576973pubmed:year1987lld:pubmed
pubmed-article:3576973pubmed:articleTitleStructural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus.lld:pubmed
pubmed-article:3576973pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3576973pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3576973pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3576973lld:pubmed